-

Vision. Passion. Persistence. These are the hallmarks of exceptional entrepreneurs. For over 30 years, we've seen the impact that small groups of talented individuals can have. As early stage investors, we've been proud to help them realize their visions. To do something that hasn't been done before. To build great companies that lead markets - and change the world. Get to know our team, gain insight into how we think, the kind of companies we invest in, and our latest technology initiatives.
-
View our full video library

We're interested in revolutionary ideas that are truly disruptive and address large, unmet market needs. We're continually exploring new technology initiatives to gain a better understanding of the opportunities and challenges that lie ahead.
Our CEOs share their perspectives on what it takes to be a successful entrepreneur.
-
Mike Peronto, CEO of WildTangent
-
John Knopf, CEO of Acceleron Pharma
-
John Nardone, Chairman/CEO of [X+1]
-
-
Our portfolio companies garner significant news coverage on their developments and milestones.
-
Verastem Climbs Post-IPO
Biopharmaceutical firm Verastem Inc. climbed in early trading after boosting the size of its deal.
The company's stock opened at $11 a share on the Nasdaq, up from its initial public...
Full Story -
Johnson & Johnson Takes Closer Look At PowerVision
PowerVision, which is developing intraocular lenses that can change shape in order to focus, added $4 million over the summer to its Series C round, as medical-device giant Medtronic sought a...
Full Story
-